Biotech
-
Greg Fenton of Zentek on Customer Demand for its Innovative Antimicrobial Coating for HVAC Systems
In this InvestorIntel interview, Tracy Weslosky talks with Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg…
-
NetraMark is Unleashing the Power of Artificial Intelligence to Revolutionize the Pharmaceutical Industry
The market is awash with the talk of Artificial Intelligence (AI) and Machine Learning (ML). The most recent…
-
Thomas Smeenk Discusses the Intersection of Hemostemix’s NCP Treatment and Elon Musk’s Neuralink
In this InvestorIntel interview, Tracy Weslosky talks with Hemostemix Inc.’s (TSXV: HEM | OTCQB: HMTXF) Co-Founder, CEO, and President…
-
Cardiol Furthers Clinical Trials to Advance Disruptive Cannabidiol-Based Therapies for Heart Disease
Heart disease continues to be a leading cause of death globally. According to Cardiol Therapeutics Inc. (NASDAQ: CRDL…
-
Promising Advancements in Gene Therapy are Leading to Potential Investment Opportunities
Today’s discussion is about a topic that fascinates me even though I can say that I do not…
-
Jon Gluckman of Sixth Wave Innovations Discusses Its Lithium and Gold Extraction Technology
In this InvestorIntel interview during PDAC 2023, Tracy Weslosky talks to Sixth Wave Innovations Inc.’s (CSE: SIXW |…
-
Valeo Pharma Impresses Again with 210% Quarterly Year-over-Year Revenue Growth
Valeo Pharma Inc. (TSX: VPH | OTCQB: VPHIF) (“Valeo”) just released their FQ1/2023 earnings results and impressed again.…
-
Hemostemix Plans to Revolutionize Stem Cell Therapy with Scalable Production and New Sales Goals
Hemostemix Inc. (TSXV: HEM | OTCQB: HMTXF | FSE: 2VF0) has developed an effective “stem cell therapy” for…
-
Steve Saviuk, CEO of Valeo Pharma, Discusses Promising Results of COVID-19 Drug Sabizabulin and Revenue Growth in 2023
In this InvestorIntel interview, Tracy Weslosky talks to Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO, and…
